Drug & intervention

olsalazine sodium 250 MG Oral Capsule [Dipentum]

RxCUI 905164

What this record represents

SBD · RxNorm

This is an RxNorm SBD drug concept. Its name, formulation details and source identifiers are preserved to distinguish it from other drug records.

What this record does not establish: current marketing availability, therapeutic equivalence, safety, or official approval status. Check an up-to-date product label or a pharmacist for product-specific questions.

Inspect the RxNorm source identifier

Related drug records

RxNorm name matches

These are other published drug concepts with matching brand or formulation names. They are not necessarily equivalent medicines.

DipentumBN · CureCurrent ID 21304
olsalazine Oral Capsule [Dipentum]SBDF · CureCurrent ID 30313
olsalazine sodium 250 MG [Dipentum]SBDC · CureCurrent ID 45643

Molecular structure

Active ingredient: olsalazine sodium
Molecular structure illustration of olsalazine sodium
RxNorm RxCUI 104123 · PubChem CID 135413505 · C14H8N2Na2O6. Verify structure at PubChem. This drawing represents the matched chemical ingredient, not necessarily a complete multi-ingredient branded product.
Clinical trials0
Recruiting0
Related conditions0
Synonyms3
Advertisement

Active ingredients and chemical structures

RxNorm ingredient relationships. Structures are retrieved by PubChem compound identifier when available. An ingredient can have both a base and a precise salt concept.

2D chemical structure of olsalazine sodium olsalazine sodium RxCUI 104123 · Precise ingredient View ingredient recordPubChem CID 135413505

Conditions being studied

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.